HealthStream Inc

HealthStream Inc(HSTM)股票分析

$33.130

-0.610 (-1.84%)收盘时

Loading chart…
最高
34.180
开盘
33.950
成交量加权均价
33.33
成交量
207.26K
市值
846.58M
最低
32.670
成交额
6.91M
企业价值/息税折旧摊销前利润(TTM)
12.70

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.

AI 分析 of HealthStream Inc (HSTM)

持有

HealthStream Inc is currently trading at $33.13, which is above the analyst target price of $27, indicating it may be overvalued at this time. The RSI is at 64.45, suggesting it is nearing overbought territory, while the forward P/E ratio is 33.78, which is relatively high compared to industry averages. The recent earnings report showed a significant EPS of $0.23, up from $0.18 year-over-year, reflecting strong profitability. However, insider selling has increased by 146.37%, which raises concerns about insider confidence in the stock's future performance.

分析师评级(9)

-24.54% 下跌空间
持有
4 买入
5 持有
0 卖出
当前: 33.13
最低
25.00
平均
25.00
最高
25.00

Canaccord

2026-07-21

目标价

$27

持有

Canaccord

2026-05-06

目标价

$24

持有

Canaccord

2026-02-25

目标价

$21

持有

Canaccord

2026-01-08

目标价

$25

持有

Canaccord

2025-08-07

目标价

$28

持有

估值指标

HealthStream Inc(HSTM)当前预期市盈率为 33.78,5 年平均预期市盈率为 55.03。

预期市盈率

合理
5 年均值 P/E
55.03
当前P/E
33.78
高估
78.96
低估
31.09

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.58
当前EV/EBITDA
12.70
高估
13.24
低估
9.92

预期市销率

高估
5 年均值 P/S
2.62
当前P/S
3.00
高估
3.00
低估
2.24

Alphio AI 对 HSTM 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%HSTM

$27.38

情景价格

基

基准

基准 · 50%HSTM

$25.98

情景价格

悲

悲观

悲观 · 25%HSTM

$21.36

情景价格

持有 HSTM 的大户

P

Punch & Associates Investment Management, Inc.

+ 持有HSTM

-5.54%

3个月收益率

事件时间线

2026-08-11 (ET)

08:30:00

Humana Collaborates with HealthStream to Expand Healthcare Services in Indiana

2026-08-03 (ET)

17:00:00

Company Reports Q2 Revenue of $83.7M

17:00:00

Now Projects 2026 Adjusted EBITDA of $74M-$78M

2026-05-04 (ET)

16:40:00

HealthStream Promotes Michael M. Collier to Chief Operating Officer

16:40:00

Company Confirms FY26 Adjusted EBITDA Outlook of $73M-$77M

资讯

HSTM 常见问题 —— 由 Alphio AI 解答

HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ET industry).

HealthStream Inc is currently trading at $33.13, which is above the analyst target price of $27, indicating it may be overvalued at this time. The RSI is at 64.45, suggesting it is nearing overbought territory, while the forward P/E ratio is 33.78, which is relatively high compared to industry averages. The recent earnings report showed a significant EPS of $0.23, up from $0.18 year-over-year, reflecting strong profitability. However, insider selling has increased by 146.37%, which raises concerns about insider confidence in the stock's future performance.

9 analysts cover HSTM: 4 rate it Buy, 5 Hold and 0 Sell. The average price target is 25.00.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易